North America Whole Exome Sequencing Market to Grow at an Impressive CAGR of 22.0% by 2029

PRESS RELEASE

Published February 15, 2023

Data Bridge Market research has recently released expansive research titled “North America Whole Exome Sequencing Market” guarantees you will remain better informed than your competition. This study provides the broader perspective of the market place with its comprehensive market insights and analysis which eases surviving and succeeding in the market.

North America Whole Exome Sequencing Market Growing Popularity and Business Analysis Research Report (2022 – 2029). The market research data included in the large scale North America Whole Exome Sequencing Market research report is analysed and forecasted using market statistical and coherent models.

Grab Sample Report with Complete Graphs, Charts and Figures @ www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-whole-exome-sequencing-market

North America whole exome sequencing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 22.0% in the forecast period of 2022 to 2029. Increasing the preference of WES over whole-genome sequencing due to its low-cost sequencing capability are the major factors for drive the market growth in the forecast period.

Market Outline: –

Whole exome is a genomic technique for sequencing all of the protein-coding region of genes in a genome. Whole exome sequencing is available to patients who are searching for a unifying diagnosis for multiple medical conditions. A laboratory process that is used to determine the nucleotide sequence primarily of the exonic (or protein-coding) regions of an individual’s genome and related sequences, representing approximately 1% of the complete DNA sequence, also called WES. Whole-exome sequencing is a widely used whole exome sequencing method that involves sequencing the protein-coding regions of the genome. The human exome represents less than 2% of the genome, but contains ~85% of known disease-related variants, making this method a cost-effective alternative to whole-genome sequencing.

Exome sequencing using exome enrichment can efficiently detect coding variants across a wide range of applications, including population genetics, genetic disease and cancer studies. The growth of the global whole exome sequencing market is attributed to the reduction in time and cost for sequencing. With the development of new technologies and cancer cure treatment, the whole exome sequencing market in clinical oncology has huge potential in the coming years.

Some of the major players operating in the North America Whole Exome Sequencing Market are

Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Beckman Coulter, Inc., Eurofins Scientific, BIONEER CORPORATION, ExoDx (a part of Bio-Techne), FOUNDATION MEDICINE, INC. (A subsidiary of F. Hoffmann-La Roche Ltd), GeneFirst Limited, CeGaT GmbH, Meridian, Merck KGaA, SOPHiA GENETICS, Azenta U.S. Inc., CD Genomics, Twist Bioscience, PerkinElmer Genomics (A Subsidiary of PerkinElmer Inc.), GeneDx, LLC, Psomagen, Integrated DNA Technologies, Inc., among others.

Access Full 350 Pages PDF Report @ www.databridgemarketresearch.com/reports/north-america-whole-exome-sequencing-market

Recent Development

  • In May, 2022, Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab populations globally. This has helped the company to expand its presence.
  • In March, 2022, several leading genomics companies and laboratories, including Illumina, Fulgent Genetics, Invitae, GeneDx, and PerkinElmer Genomics, have formed the CardioGenomic Testing Alliance (CGTA), a collaborative group aimed at raising awareness and utilization of genomic testing in cardiology. CGTA seeks to educate healthcare providers and other stakeholders about the value of such testing to assure adherence to existing guidelines from professional medical societies, to inform medical management and cascade testing, and to improve clinical outcomes. This has helped company to adhere to guidelines.

Table of Content:

Section 01: Executive Summary

Section 02: Scope of The Report

Section 03: Research Methodology

Section 04: Introduction

Section 05: Market Landscape

Section 06: Market Sizing

Section 07: Five Forces Analysis

Section 08: Market Segmentation by Product

Section 09: Market Segmentation by Application

Section 10: Customer Landscape

Section 11: Market Segmentation by End-User

Section 12: Regional Landscape

Section 13: Decision Framework

Section 14: Drivers and Challenges

Section 15: Market Trends

Section 16: Competitive Landscape

Section 17: Company Profiles

Section 18: Appendix

For More Insights Get Detailed TOC @ www.databridgemarketresearch.com/toc/?dbmr=north-america-whole-exome-sequencing-market

North America Whole Exome Sequencing Market Segmentation

North America whole exome sequencing market is segmented on the basis of component, product and service, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Component

  • Second-Generation Sequencing
  • Third-Generation Sequencing

On the basis of component, the North America whole exome sequencing market is segmented into second-generation sequencing and third-generation sequencing.

Product and Services

On the basis of product and service, the North America whole exome sequencing market is segmented into systems, kits and services.

Application

  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Agriculture & Animal Research
  • Others

On the basis of application, the North America whole exome sequencing market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.

End User

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Clinical Laboratories
  • Others

On the basis of end user, the North America whole exome sequencing market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & clinics, clinical laboratories and others.

Distribution Channel

  • Direct Trade
  • Retail sales
  • Others

Reasons to Consider This Report?

  • The report offers a comprehensive evaluation of the North America Whole Exome Sequencing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

The Study Objectives of the North America Whole Exome Sequencing Market Research Report are:

  1. To examine deeply on the existing status, future forecast, growth opportunity, key market and industry players.
  2. To display the current development in major economies, across the globe.
  3. To strategically profile the market players and comprehensively examine their growth and development plans.
  4. To define, describe and predict the North America Whole Exome Sequencing Market by product type, application, end user, and key regions.

Browse Trending Reports:

 North America Wound Care Biologics Market Size, Share and Opportunities www.databridgemarketresearch.com/reports/north america wound care biologics market

 North America Soft Tissue Repair Market Size, Share and Opportunities www.databridgemarketresearch.com/reports/north america soft tissue repair market

 North America Electrophysiology Market Size, Share and Opportunities www.databridgemarketresearch.com/reports/north america electrophysiology market

 North America Skin Tightening Market Size, Share and Opportunities www.databridgemarketresearch.com/reports/north america skin tightening market

 North America Biopreservation Market Size, Share and Opportunities www.databridgemarketresearch.com/reports/north america biopreservation market

 North America Cell Counting Devices Market Size, Share and Opportunities www.databridgemarketresearch.com/reports/north america cell counting devices market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Read more here: Source link